A Risk Score to Predict Intracranial Hemorrhage After Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 17, Issue 6, 2008, Pages 331-333

  Cucchiara, Brett ^a   Tanne, David ^b   Levine, Steven R ^c   Demchuk, Andrew M ^d   Kasner, Scott ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

acute ischemic stroke; Intracerebral hemorrhage; risk scores; thrombolysis

Indexed keywords

ALTEPLASE; GLUCOSE;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SYMPTOMATOLOGY; THROMBOCYTE COUNT;

AGE FACTORS; BLOOD COAGULATION DISORDERS; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; FIBRINOLYTIC AGENTS; HUMANS; HYPERGLYCEMIA; PATIENT SELECTION; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 54949153147     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.03.012     Document Type: Article

References (6)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
2. Tanne D., Kasner S.E., Demchuk A.M., et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The multicenter rt-pa stroke survey. Circulation 105 (2002) 1679-1685
3. The NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28 (1997) 2109-2118
4. Lansberg M.G., Albers G.W., and Wijman C.A. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: A review of the risk factors. Cerebrovasc Dis 24 (2007) 1-10
5. Marti-Fabregas J., Bravo Y., Cocho D., et al. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials. Cerebrovasc Dis 23 (2007) 85-90
6. Castellanos M., Sobrino T., Millan M., et al. Plasma MMP-9 and fibronectin levels confirm their value as powerful predictors of hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke: A multicenter prospective study. Stroke 38 (2007) 463